Gary L Mossman, Dipexium Pharmaceuticals, Inc.'s Chief Operating Officer, recently acquired 87,946 shares of the company. The buys took place at $0.00 per share, on April 19, 2017. Mossman now owns 87,946 shares of the company. Mossman operates out of Houston, TX. Some additional info was provided as follows:

Received in exchange for 90,130 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.). Received in exchange for 18,989 shares of common stock of PLx Opco Inc. in connection with the Merger. Received in exchange for 2,552 shares of common stock of PLx Opco Inc. in connection with the Merger. The Rep orting Person disclaims beneficial ownership of these shares. Received in connection with the Merger in exchange for an employee stock option to buy 88,571 shares of PLx Opco Inc. common stock for $9.80 per share. The option is exercisable as to 51,754 shares as of the date hereof, and will become exercisable as to an additional 18,001 shares on July 22, 2017 (generally subject to continued employment or consulting relationship through such date).

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: Loss per share Basic... - Nov. 9, 2017
Departure of Directors or Certain - Oct. 27, 2017

Auto Refresh